CheckMan Stock Market Overview

Marvell Technology (NASDAQ:MRVL | MRVL Price Prediction) is acquiring Lumentum Holdings (NASDAQ:LITE). The all-stock agreement is reshaping the map of AI data center optics, and both companies are sliding as the market considers the price.

When you're drawing income from a portfolio, the check size matters less than whether it keeps coming every year. A blue-chip payout is funded by free cash flow left over after the business reinvests in itself.

Stellantis chip shortage disrupts Fiat output in Italy, may last through December

Realty Income stock has lost momentum in the past two weeks, even as US bond yields have pulled back. The dividend giant ended last week at $56.93, a few points below the October high of $57.6.

The complaint alleges that Endava plc misled investors regarding its accounting treatment of certain customer and supplier agreements and related matters.

ST. LOUIS and ROUEN, France, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the findings from the first-in-human clinical results for Robocath's next-generation robotic system during the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. The findings support a favorable performance profile for the system, with 100% clinical success rate and no device-related complications.

A Dividend Aristocrat is an S&P 500 company that has raised its dividend for at least 25 consecutive years.

Mounjaro and Zepbound just handed Lilly a blowout quarter, but falling realized drug prices and one-time revenue boosts that won't repeat raise real questions about whether the rally holds from here.

Marvell is buying AI laser maker Lumentum in a $115 billion all-stock deal that leaves current Marvell shareholders owning about two-thirds of the combined company. Lumentum's revenue just jumped 136.5% to $1.26 billion, and Marvell says the deal should add to its adjusted earnings per share in the first year after closing.

Cardinal Health CAH is scheduled to report first-quarter fiscal 2027 results on Nov. 5, before the market opens. The company entered the quarter with strong pharmaceutical demand, expanding specialty operations and ongoing improvement initiatives in its medical distribution business.